sampleID;histological_type;mRNA_subtype;mRNA_cluster;methylation_cluster;pathologic_T;clinical_M;pathologic_N;age;gender;overall_survival;overall_survival_months;days_to_death;days_to_last_followup;disease_status;disease_free_months
TCGA-2A-A8VL;NA;1-ERG;3;3;;;;NA;NA;NA;NA;NA;NA;NA;NA
TCGA-2A-A8VO;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;;57;MALE;Alive;55.88;NA;1332;DiseaseFree;55.88
TCGA-2A-A8VT;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T4;M0;N1;47;MALE;Alive;45.11;NA;995;DiseaseFree;45.11
TCGA-2A-A8VV;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;52;MALE;Alive;22.04;NA;671;DiseaseFree;22.04
TCGA-2A-A8VX;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;70;MALE;Alive;45.27;NA;1033;DiseaseFree;45.27
TCGA-2A-A8W1;Prostate Adenocarcinoma Acinar Type;2-ETV1;1;4;T3;M0;N0;54;MALE;Alive;3.68;NA;112;DiseaseFree;3.68
TCGA-2A-A8W3;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;1;T3;M0;N0;69;MALE;Alive;28.35;NA;771;Recurred/Progressed;6.5
TCGA-2A-AAYF;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;;57;MALE;Alive;44.81;NA;972;DiseaseFree;44.81
TCGA-2A-AAYO;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;57;MALE;Alive;41.79;NA;922;DiseaseFree;41.79
TCGA-2A-AAYU;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;56;MALE;Alive;20.2;NA;615;DiseaseFree;20.2
TCGA-4L-AA1F;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M1;N0;64;MALE;Alive;11.5;NA;350;DiseaseFree;11.5
TCGA-CH-5737;Prostate Adenocarcinoma Acinar Type;6-FOXA1;1;2;T2;M0;N0;73;MALE;Alive;2.99;NA;91;DiseaseFree;2.99
TCGA-CH-5738;Prostate Adenocarcinoma Acinar Type;4-FLI1;3;3;;M0;;72;MALE;Alive;6.96;NA;212;DiseaseFree;6.96
TCGA-CH-5739;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;65;MALE;Alive;22.04;NA;671;DiseaseFree;22.04
TCGA-CH-5740;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;57;MALE;Alive;1.02;NA;31;DiseaseFree;1.02
TCGA-CH-5741;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;56;MALE;Alive;12.98;NA;395;DiseaseFree;12.98
TCGA-CH-5743;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T2;M0;N0;66;MALE;Alive;13.96;NA;425;Recurred/Progressed;13.96
TCGA-CH-5744;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;64;MALE;Alive;1.97;NA;60;DiseaseFree;1.97
TCGA-CH-5745;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;68;MALE;Alive;2.99;NA;91;DiseaseFree;2.99
TCGA-CH-5746;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;57;MALE;Alive;24.01;NA;731;DiseaseFree;24.01
TCGA-CH-5748;Prostate Adenocarcinoma Acinar Type;2-ETV1;1;4;T3;;N0;64;MALE;Alive;1.02;NA;31;DiseaseFree;1.02
TCGA-CH-5750;Prostate Adenocarcinoma Acinar Type;2-ETV1;2;2;T2;M0;N0;72;MALE;Alive;13.01;NA;396;DiseaseFree;13.01
TCGA-CH-5751;Prostate Adenocarcinoma Acinar Type;8-other;2;2;T4;M0;N1;68;MALE;Alive;34.99;NA;1065;Recurred/Progressed;11.99
TCGA-CH-5752;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;66;MALE;Alive;30.98;NA;943;DiseaseFree;30.98
TCGA-CH-5753;Prostate Adenocarcinoma Acinar Type;2-ETV1;2;2;T3;M0;N1;70;MALE;Alive;1.02;NA;31;DiseaseFree;1.02
TCGA-CH-5754;Prostate Adenocarcinoma Acinar Type;1-ERG;2;4;T3;M0;N1;65;MALE;Alive;2.04;NA;62;DiseaseFree;2.04
TCGA-CH-5761;Prostate Adenocarcinoma Acinar Type;8-other;2;2;T3;M0;N0;61;MALE;Alive;0.92;NA;28;DiseaseFree;0.92
TCGA-CH-5762;Prostate Adenocarcinoma Acinar Type;3-ETV4;3;2;T3;M0;N0;60;MALE;Alive;43.99;NA;1339;DiseaseFree;43.99
TCGA-CH-5763;Prostate Adenocarcinoma Acinar Type;3-ETV4;3;4;T3;M0;N0;66;MALE;Alive;11.99;NA;365;DiseaseFree;11.99
TCGA-CH-5764;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;66;MALE;Alive;1.02;NA;31;DiseaseFree;1.02
TCGA-CH-5765;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;55;MALE;Alive;23;NA;700;DiseaseFree;23
TCGA-CH-5766;Prostate Adenocarcinoma Acinar Type;1-ERG;2;4;T3;M0;N1;55;MALE;Alive;1.02;NA;31;DiseaseFree;1.02
TCGA-CH-5767;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;N0;66;MALE;Alive;15.05;NA;458;DiseaseFree;15.05
TCGA-CH-5768;Prostate Adenocarcinoma Acinar Type;1-ERG;3;2;T3;M0;N0;72;MALE;Alive;24.01;NA;731;DiseaseFree;24.01
TCGA-CH-5769;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;48;MALE;Alive;2.04;NA;62;DiseaseFree;2.04
TCGA-CH-5771;Prostate Adenocarcinoma Acinar Type;3-ETV4;3;4;T2;M0;N0;63;MALE;Alive;13.01;NA;396;DiseaseFree;13.01
TCGA-CH-5772;Prostate Adenocarcinoma Acinar Type;7-IDH1;1;2;T3;M0;N0;63;MALE;Alive;15.97;NA;486;DiseaseFree;15.97
TCGA-CH-5788;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N1;69;MALE;Alive;26.97;NA;821;DiseaseFree;26.97
TCGA-CH-5789;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T3;M0;N0;61;MALE;Alive;9.99;NA;304;DiseaseFree;9.99
TCGA-CH-5790;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;64;MALE;Alive;32;NA;974;DiseaseFree;32
TCGA-CH-5791;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;72;MALE;Alive;32.98;NA;1004;Recurred/Progressed;32
TCGA-CH-5792;Prostate Adenocarcinoma Acinar Type;8-other;3;2;T3;M0;N0;57;MALE;Alive;2.99;NA;91;DiseaseFree;2.99
TCGA-CH-5794;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;65;MALE;Alive;28.98;NA;882;DiseaseFree;28.98
TCGA-EJ-5494;Prostate Adenocarcinoma Acinar Type;6-FOXA1;3;2;T3;M0;N0;50;MALE;Alive;48.52;NA;378;DiseaseFree;48.52
TCGA-EJ-5495;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T3;M0;N1;68;MALE;Alive;57.82;NA;606;DiseaseFree;57.82
TCGA-EJ-5496;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;59;MALE;Alive;19.55;NA;595;DiseaseFree;19.55
TCGA-EJ-5497;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;47;MALE;Alive;13.3;NA;405;DiseaseFree;13.3
TCGA-EJ-5498;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;;N0;56;MALE;Alive;56.5;NA;537;DiseaseFree;56.5
TCGA-EJ-5499;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T3;M0;N0;61;MALE;Alive;46.48;NA;533;DiseaseFree;46.48
TCGA-EJ-5501;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;4;T3;M0;N0;55;MALE;Alive;44.84;NA;729;DiseaseFree;44.84
TCGA-EJ-5502;Prostate Adenocarcinoma Acinar Type;1-ERG;1;3;T2;M0;N0;50;MALE;Alive;38.47;NA;245;DiseaseFree;38.47
TCGA-EJ-5503;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T3;M0;N0;50;MALE;Alive;45.7;NA;530;DiseaseFree;45.7
TCGA-EJ-5504;Prostate Adenocarcinoma Acinar Type;2-ETV1;1;2;T3;M0;N1;65;MALE;Alive;46.88;NA;229;DiseaseFree;46.88
TCGA-EJ-5505;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;57;MALE;Alive;30.29;NA;448;DiseaseFree;30.29
TCGA-EJ-5506;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T3;M0;N1;67;MALE;Alive;45.37;NA;356;DiseaseFree;45.37
TCGA-EJ-5507;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;54;MALE;Alive;47.86;NA;182;DiseaseFree;47.86
TCGA-EJ-5508;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;65;MALE;Alive;64.55;NA;907;DiseaseFree;64.55
TCGA-EJ-5509;Prostate Adenocarcinoma Acinar Type;5-SPOP;3;2;T2;M0;N0;63;MALE;Alive;48.09;NA;1102;DiseaseFree;48.09
TCGA-EJ-5510;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;4;T2;M0;N0;48;MALE;Alive;61.99;NA;738;DiseaseFree;61.99
TCGA-EJ-5511;Prostate Adenocarcinoma Acinar Type;3-ETV4;1;4;T3;M0;N0;55;MALE;Alive;48.49;NA;788;DiseaseFree;48.49
TCGA-EJ-5512;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;46;MALE;Alive;56.93;NA;782;DiseaseFree;56.93
TCGA-EJ-5514;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;N0;66;MALE;Alive;60.09;NA;724;DiseaseFree;60.09
TCGA-EJ-5515;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T3;M0;N0;60;MALE;Alive;60.18;NA;1061;DiseaseFree;60.18
TCGA-EJ-5516;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;49;MALE;Alive;62.06;NA;783;DiseaseFree;62.06
TCGA-EJ-5517;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;55;MALE;Alive;62.06;NA;850;DiseaseFree;62.06
TCGA-EJ-5518;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T4;M0;N0;66;MALE;Alive;69.58;NA;1195;Recurred/Progressed;69.12
TCGA-EJ-5519;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;4;T3;M0;N1;64;MALE;Alive;64.45;NA;1153;DiseaseFree;64.45
TCGA-EJ-5521;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;63;MALE;Alive;74.87;NA;842;DiseaseFree;74.87
TCGA-EJ-5522;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;51;MALE;Alive;68.3;NA;1403;DiseaseFree;68.3
TCGA-EJ-5524;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;57;MALE;Alive;61.83;NA;834;Recurred/Progressed;8.71
TCGA-EJ-5525;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;67;MALE;Alive;36.63;NA;790;Recurred/Progressed;17.94
TCGA-EJ-5526;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T3;M0;N1;56;MALE;Alive;62.71;NA;567;Recurred/Progressed;62.71
TCGA-EJ-5527;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T3;M0;N0;69;MALE;Alive;58.41;NA;397;DiseaseFree;58.41
TCGA-EJ-5530;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;61;MALE;Alive;60.18;NA;1272;DiseaseFree;60.18
TCGA-EJ-5531;Prostate Adenocarcinoma Acinar Type;5-SPOP;3;4;T3;M0;N0;62;MALE;Alive;41.82;NA;724;DiseaseFree;41.82
TCGA-EJ-5532;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;N0;57;MALE;Alive;60.05;NA;926;DiseaseFree;60.05
TCGA-EJ-5542;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;60;MALE;Alive;49.7;NA;519;DiseaseFree;49.7
TCGA-EJ-7115;Prostate Adenocarcinoma Acinar Type;5-SPOP;3;2;T3;M0;N0;65;MALE;Alive;88.27;NA;822;DiseaseFree;88.27
TCGA-EJ-7123;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;59;MALE;Alive;84.49;NA;1491;DiseaseFree;84.49
TCGA-EJ-7125;Prostate Adenocarcinoma Acinar Type;7-IDH1;1;2;T2;M0;N0;44;MALE;Alive;93.63;NA;1860;DiseaseFree;93.63
TCGA-EJ-7218;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;71;MALE;Alive;83.51;NA;2542;DiseaseFree;83.51
TCGA-EJ-7312;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;58;MALE;Alive;36.1;NA;663;DiseaseFree;36.1
TCGA-EJ-7314;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T3;M0;N0;62;MALE;Alive;37.78;NA;295;DiseaseFree;37.78
TCGA-EJ-7315;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;68;MALE;Alive;33.11;NA;289;DiseaseFree;33.11
TCGA-EJ-7317;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;N0;71;MALE;Alive;25.33;NA;285;DiseaseFree;25.33
TCGA-EJ-7318;Prostate Adenocarcinoma Acinar Type;2-ETV1;1;2;T3;M0;;51;MALE;Alive;33.8;NA;510;Recurred/Progressed;12.48
TCGA-EJ-7321;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;57;MALE;Alive;27.07;NA;233;DiseaseFree;27.07
TCGA-EJ-7325;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;63;MALE;Alive;35.15;NA;533;DiseaseFree;35.15
TCGA-EJ-7327;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;61;MALE;Alive;30.32;NA;175;DiseaseFree;30.32
TCGA-EJ-7328;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T3;M0;N0;70;MALE;Alive;27.66;NA;170;DiseaseFree;27.66
TCGA-EJ-7330;Prostate Adenocarcinoma Acinar Type;5-SPOP;3;2;T3;M0;N0;68;MALE;Alive;6.27;NA;191;DiseaseFree;6.27
TCGA-EJ-7331;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T2;M0;N0;64;MALE;Alive;24.38;NA;9;DiseaseFree;24.38
TCGA-EJ-7781;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T2;M0;N0;65;MALE;Alive;35.25;NA;169;DiseaseFree;35.25
TCGA-EJ-7782;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;71;MALE;Alive;38.34;NA;350;DiseaseFree;38.34
TCGA-EJ-7783;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T3;M0;N0;70;MALE;Alive;25.85;NA;172;DiseaseFree;25.85
TCGA-EJ-7784;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T2;M0;N0;63;MALE;Alive;25.66;NA;167;DiseaseFree;25.66
TCGA-EJ-7785;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;54;MALE;Alive;38.67;NA;259;DiseaseFree;38.67
TCGA-EJ-7786;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;62;MALE;Alive;36.01;NA;79;DiseaseFree;36.01
TCGA-EJ-7788;Prostate Adenocarcinoma Acinar Type;2-ETV1;1;2;T3;M0;N0;53;MALE;Alive;28.22;NA;52;DiseaseFree;28.22
TCGA-EJ-7789;Prostate Adenocarcinoma Acinar Type;6-FOXA1;1;2;T3;M0;N0;66;MALE;Alive;36.3;NA;70;DiseaseFree;36.3
TCGA-EJ-7791;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T2;M0;N0;67;MALE;Alive;36.73;NA;217;DiseaseFree;36.73
TCGA-EJ-7792;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;53;MALE;Alive;45.86;NA;526;DiseaseFree;45.86
TCGA-EJ-7793;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;;49;MALE;Alive;3.75;NA;114;DiseaseFree;3.75
TCGA-EJ-7794;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T2;M0;N0;67;MALE;Alive;42.9;NA;285;DiseaseFree;42.9
TCGA-EJ-7797;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;53;MALE;Alive;32.29;NA;187;DiseaseFree;32.29
TCGA-EJ-8468;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;;N0;63;MALE;Alive;77.1;NA;1961;DiseaseFree;77.1
TCGA-EJ-8469;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;46;MALE;Alive;76.35;NA;1946;Recurred/Progressed;63.24
TCGA-EJ-8470;Prostate Adenocarcinoma Acinar Type;8-other;3;2;T2;M0;N0;58;MALE;Alive;38.07;NA;821;DiseaseFree;38.07
TCGA-EJ-8472;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;63;MALE;Alive;24.84;NA;756;Recurred/Progressed;6.44
TCGA-EJ-8474;Prostate Adenocarcinoma Acinar Type;2-ETV1;2;2;T3;M0;N0;69;MALE;Alive;25.16;NA;314;DiseaseFree;25.16
TCGA-EJ-A46B;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;66;MALE;Alive;21.58;NA;162;DiseaseFree;21.58
TCGA-EJ-A46D;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;53;MALE;Alive;20.57;NA;129;DiseaseFree;20.57
TCGA-EJ-A46E;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;;M0;N0;57;MALE;Alive;17.21;NA;524;DiseaseFree;17.21
TCGA-EJ-A46F;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;57;MALE;Alive;25.72;NA;299;Recurred/Progressed;7.06
TCGA-EJ-A46G;Prostate Adenocarcinoma, Other Subtype;8-other;1;2;T3;M0;N0;71;MALE;Alive;21.94;NA;93;DiseaseFree;21.94
TCGA-EJ-A46H;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;60;MALE;Alive;23.78;NA;229;DiseaseFree;23.78
TCGA-EJ-A46I;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T3;M0;N0;57;MALE;Alive;21.94;NA;668;DiseaseFree;21.94
TCGA-EJ-A65B;Prostate Adenocarcinoma, Other Subtype;NA;NA;NA;T3;M0;N0;55;MALE;Alive;23.32;NA;536;DiseaseFree;23.32
TCGA-EJ-A65D;Prostate Adenocarcinoma, Other Subtype;NA;NA;NA;T3;M0;N0;66;MALE;Alive;12.91;NA;393;DiseaseFree;12.91
TCGA-EJ-A65E;Prostate Adenocarcinoma, Other Subtype;5-SPOP;1;2;T3;M0;N0;67;MALE;Alive;13.7;NA;417;DiseaseFree;13.7
TCGA-EJ-A65F;Prostate Adenocarcinoma, Other Subtype;1-ERG;2;1;T3;M0;N0;59;MALE;Alive;18.4;NA;560;Recurred/Progressed;2.46
TCGA-EJ-A65G;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;57;MALE;Alive;21.88;NA;278;DiseaseFree;21.88
TCGA-EJ-A65J;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N0;62;MALE;Alive;14.82;NA;91;DiseaseFree;14.82
TCGA-EJ-A65M;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;65;MALE;Alive;7.56;NA;230;DiseaseFree;7.56
TCGA-EJ-A6RA;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T3;M0;N1;70;MALE;Alive;11.6;NA;353;Recurred/Progressed;11.6
TCGA-EJ-A6RC;Prostate Adenocarcinoma Acinar Type;8-other;1;4;;M0;N0;64;MALE;Alive;28.68;NA;693;DiseaseFree;28.68
TCGA-EJ-A7NF;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;56;MALE;Alive;8.21;NA;216;DiseaseFree;8.21
TCGA-EJ-A7NG;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T3;M0;N0;64;MALE;Alive;14.19;NA;264;DiseaseFree;14.19
TCGA-EJ-A7NH;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;4;T2;M0;N0;56;MALE;Alive;15.57;NA;172;DiseaseFree;15.57
TCGA-EJ-A7NJ;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T2;M0;N0;59;MALE;Alive;6.47;NA;197;DiseaseFree;6.47
TCGA-EJ-A7NK;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T3;M0;N0;58;MALE;Alive;15.64;NA;295;DiseaseFree;15.64
TCGA-EJ-A7NM;Prostate Adenocarcinoma, Other Subtype;3-ETV4;2;2;T3;M0;N1;64;MALE;Alive;4.2;NA;128;DiseaseFree;4.2
TCGA-EJ-A7NN;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;61;MALE;Alive;6.47;NA;197;Recurred/Progressed;6.47
TCGA-EJ-A8FN;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;58;MALE;Alive;10.81;NA;203;DiseaseFree;10.81
TCGA-EJ-A8FO;Prostate Adenocarcinoma, Other Subtype;NA;NA;NA;T3;M0;N0;51;MALE;Alive;9.26;NA;156;DiseaseFree;9.26
TCGA-EJ-A8FP;Prostate Adenocarcinoma, Other Subtype;NA;NA;NA;T2;M0;N0;59;MALE;Alive;9.82;NA;117;Recurred/Progressed;3.84
TCGA-EJ-A8FS;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N0;66;MALE;Alive;8.74;NA;216;Recurred/Progressed;7.1
TCGA-EJ-A8FU;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;4;T3;M0;N0;64;MALE;Alive;4.53;NA;82;DiseaseFree;4.53
TCGA-EJ-AB20;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;61;MALE;Alive;4.3;NA;131;DiseaseFree;4.3
TCGA-EJ-AB27;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;51;MALE;Alive;4.76;NA;145;DiseaseFree;4.76
TCGA-FC-7708;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T3;M0;N0;52;MALE;Alive;28.38;NA;32;DiseaseFree;28.38
TCGA-FC-7961;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N0;62;MALE;Alive;15.41;NA;70;DiseaseFree;15.41
TCGA-FC-A4JI;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;;70;MALE;Alive;28.81;NA;29;DiseaseFree;28.81
TCGA-FC-A5OB;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N0;53;MALE;Alive;22.34;NA;273;DiseaseFree;22.34
TCGA-FC-A66V;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;74;MALE;Alive;17.21;NA;122;DiseaseFree;17.21
TCGA-FC-A6HD;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;77;MALE;Alive;25.92;NA;54;DiseaseFree;25.92
TCGA-FC-A8O0;Prostate Adenocarcinoma Acinar Type;8-other;3;3;T3;M0;N0;68;MALE;Alive;20.24;NA;54;DiseaseFree;20.24
TCGA-G9-6329;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;;67;MALE;Alive;41.59;NA;923;DiseaseFree;41.59
TCGA-G9-6332;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;55;MALE;Alive;87.29;NA;2328;Recurred/Progressed;42.21
TCGA-G9-6333;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;66;MALE;Alive;80.98;NA;1925;DiseaseFree;80.98
TCGA-G9-6336;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;;M0;N0;57;MALE;Alive;67.94;NA;1669;DiseaseFree;67.94
TCGA-G9-6338;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;61;MALE;Alive;66.62;NA;1649;DiseaseFree;66.62
TCGA-G9-6339;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;58;MALE;Alive;83.8;NA;2110;Recurred/Progressed;53.68
TCGA-G9-6342;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;;61;MALE;Alive;55.72;NA;1338;DiseaseFree;55.72
TCGA-G9-6343;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;62;MALE;Alive;80.49;NA;554;DiseaseFree;80.49
TCGA-G9-6347;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;59;MALE;Alive;68.63;NA;1718;DiseaseFree;68.63
TCGA-G9-6348;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;2;T2;M0;N0;68;MALE;Alive;49.77;NA;1144;DiseaseFree;49.77
TCGA-G9-6351;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;;51;MALE;Alive;67.28;NA;1215;DiseaseFree;67.28
TCGA-G9-6353;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T3;M0;;58;MALE;Alive;50.66;NA;848;DiseaseFree;50.66
TCGA-G9-6354;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;55;MALE;Alive;67.87;NA;1501;DiseaseFree;67.87
TCGA-G9-6356;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;60;MALE;Alive;47.11;NA;1000;DiseaseFree;47.11
TCGA-G9-6361;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;61;MALE;Alive;46.48;NA;1008;DiseaseFree;46.48
TCGA-G9-6362;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;57;MALE;Alive;47.4;NA;822;DiseaseFree;47.4
TCGA-G9-6363;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T4;M0;N0;64;MALE;Alive;45.27;NA;993;DiseaseFree;45.27
TCGA-G9-6364;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;72;MALE;Alive;39.36;NA;841;DiseaseFree;39.36
TCGA-G9-6365;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T4;;N0;71;MALE;Alive;44.78;NA;804;DiseaseFree;44.78
TCGA-G9-6366;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;;;61;MALE;Alive;63.96;NA;101;DiseaseFree;63.96
TCGA-G9-6367;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T3;M0;N0;60;MALE;Alive;40.14;NA;875;DiseaseFree;40.14
TCGA-G9-6369;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;55;MALE;Alive;39.91;NA;851;DiseaseFree;39.91
TCGA-G9-6370;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T3;M0;N0;52;MALE;Alive;37.98;NA;806;DiseaseFree;37.98
TCGA-G9-6371;Prostate Adenocarcinoma Acinar Type;3-ETV4;1;2;T2;M0;;58;MALE;Alive;40.28;NA;846;DiseaseFree;40.28
TCGA-G9-6373;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;;68;MALE;Alive;26.64;NA;505;DiseaseFree;26.64
TCGA-G9-6377;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;61;MALE;Alive;31.47;NA;518;DiseaseFree;31.47
TCGA-G9-6378;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;;54;MALE;Alive;37.94;NA;664;DiseaseFree;37.94
TCGA-G9-6379;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;68;MALE;Alive;58.41;NA;1393;DiseaseFree;58.41
TCGA-G9-6384;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;53;MALE;Alive;25.13;NA;390;DiseaseFree;25.13
TCGA-G9-6385;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;;66;MALE;Alive;27.27;NA;356;DiseaseFree;27.27
TCGA-G9-6494;Prostate Adenocarcinoma Acinar Type;2-ETV1;1;2;T4;M0;N0;66;MALE;Alive;58.18;NA;1442;DiseaseFree;58.18
TCGA-G9-6496;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;61;MALE;Alive;56.7;NA;1014;DiseaseFree;56.7
TCGA-G9-6498;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;;53;MALE;Alive;64.13;NA;1608;Recurred/Progressed;44.09
TCGA-G9-6499;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N0;66;MALE;Alive;50.69;NA;1109;DiseaseFree;50.69
TCGA-G9-7509;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;48;MALE;Alive;52.89;NA;1164;DiseaseFree;52.89
TCGA-G9-7510;Prostate Adenocarcinoma Acinar Type;5-SPOP;3;2;T3;M0;N0;66;MALE;Alive;38.93;NA;674;DiseaseFree;38.93
TCGA-G9-7519;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;;58;MALE;Alive;27.89;NA;457;DiseaseFree;27.89
TCGA-G9-7521;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;N1;52;MALE;Alive;30.95;NA;487;DiseaseFree;30.95
TCGA-G9-7522;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;49;MALE;Alive;35.41;NA;452;DiseaseFree;35.41
TCGA-G9-7523;Prostate Adenocarcinoma Acinar Type;7-IDH1;1;2;T3;M0;N0;44;MALE;Alive;28.15;NA;324;DiseaseFree;28.15
TCGA-G9-7525;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;64;MALE;Alive;32.65;NA;512;DiseaseFree;32.65
TCGA-G9-A9S0;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;53;MALE;Dead;25.99;791;NA;Recurred/Progressed;21.35
TCGA-G9-A9S4;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;62;MALE;Alive;29.76;NA;757;DiseaseFree;29.76
TCGA-G9-A9S7;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;55;MALE;Alive;23.92;NA;643;DiseaseFree;23.92
TCGA-H9-7775;Prostate Adenocarcinoma Acinar Type;4-FLI1;2;2;T2;;;68;MALE;Alive;6.08;NA;44;DiseaseFree;6.08
TCGA-H9-A6BX;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;;;60;MALE;Alive;30.91;NA;570;DiseaseFree;30.91
TCGA-H9-A6BY;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;;N0;63;MALE;Alive;3.68;NA;112;DiseaseFree;3.68
TCGA-HC-7075;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;;63;MALE;Alive;19.74;NA;63;DiseaseFree;19.74
TCGA-HC-7077;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;;64;MALE;Alive;69.48;NA;77;DiseaseFree;69.48
TCGA-HC-7078;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N0;69;MALE;Alive;65.21;NA;162;DiseaseFree;65.21
TCGA-HC-7079;Prostate Adenocarcinoma Acinar Type;4-FLI1;3;3;T3;M0;N0;51;MALE;Alive;38.9;NA;126;Recurred/Progressed;12.48
TCGA-HC-7080;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;66;MALE;Alive;36.33;NA;104;Recurred/Progressed;29.37
TCGA-HC-7081;Prostate Adenocarcinoma Acinar Type;1-ERG;2;2;T3;;;62;MALE;Alive;37.32;NA;72;DiseaseFree;37.32
TCGA-HC-7209;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;;N0;60;MALE;Alive;14.45;NA;41;DiseaseFree;14.45
TCGA-HC-7210;Prostate Adenocarcinoma Acinar Type;6-FOXA1;3;2;T2;;N0;74;MALE;Alive;28.52;NA;149;DiseaseFree;28.52
TCGA-HC-7211;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T2;M0;N0;62;MALE;Alive;40.11;NA;24;DiseaseFree;40.11
TCGA-HC-7212;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;56;MALE;Alive;28.58;NA;41;DiseaseFree;28.58
TCGA-HC-7213;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;53;MALE;Alive;40.05;NA;60;Recurred/Progressed;5.58
TCGA-HC-7230;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;;N0;50;MALE;Alive;32.88;NA;51;DiseaseFree;32.88
TCGA-HC-7231;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;;66;MALE;Alive;30.85;NA;72;DiseaseFree;30.85
TCGA-HC-7232;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;;;66;MALE;Alive;38.14;NA;89;Recurred/Progressed;25.16
TCGA-HC-7233;Prostate Adenocarcinoma Acinar Type;8-other;3;2;T2;;N0;73;MALE;Alive;44.51;NA;52;DiseaseFree;44.51
TCGA-HC-7736;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;N0;59;MALE;Alive;36.24;NA;22;DiseaseFree;36.24
TCGA-HC-7737;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T2;M0;N1;55;MALE;Alive;35.81;NA;64;DiseaseFree;35.81
TCGA-HC-7738;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;58;MALE;Alive;31.67;NA;81;Recurred/Progressed;13.8
TCGA-HC-7740;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T2;M0;N0;59;MALE;Alive;23.55;NA;53;DiseaseFree;23.55
TCGA-HC-7742;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;N0;58;MALE;Alive;30.81;NA;113;DiseaseFree;30.81
TCGA-HC-7744;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;46;MALE;Alive;17.44;NA;51;DiseaseFree;17.44
TCGA-HC-7745;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;;N0;65;MALE;Alive;23.69;NA;63;DiseaseFree;23.69
TCGA-HC-7747;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;52;MALE;Alive;24.57;NA;57;DiseaseFree;24.57
TCGA-HC-7748;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;;N0;60;MALE;Alive;26.02;NA;62;DiseaseFree;26.02
TCGA-HC-7749;Prostate Adenocarcinoma Acinar Type;3-ETV4;2;2;T3;M0;N0;70;MALE;Alive;23.78;NA;60;DiseaseFree;23.78
TCGA-HC-7750;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;;50;MALE;Alive;17.15;NA;34;DiseaseFree;17.15
TCGA-HC-7752;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;61;MALE;Alive;25.69;NA;98;DiseaseFree;25.69
TCGA-HC-7817;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;;52;MALE;Alive;30.49;NA;32;DiseaseFree;30.49
TCGA-HC-7818;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T2;M0;N0;66;MALE;Alive;30.81;NA;45;DiseaseFree;30.81
TCGA-HC-7819;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;53;MALE;Alive;17.84;NA;1;DiseaseFree;17.84
TCGA-HC-7820;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;;;72;MALE;Alive;24.54;NA;102;DiseaseFree;24.54
TCGA-HC-7821;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N1;54;MALE;Alive;31.41;NA;56;DiseaseFree;31.41
TCGA-HC-8213;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;;;48;MALE;Alive;19.35;NA;1;DiseaseFree;19.35
TCGA-HC-8216;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;N0;58;MALE;Alive;22.4;NA;42;DiseaseFree;22.4
TCGA-HC-8256;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;;53;MALE;Alive;28.25;NA;95;DiseaseFree;28.25
TCGA-HC-8257;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;;N1;70;MALE;Alive;23.85;NA;29;DiseaseFree;23.85
TCGA-HC-8258;Prostate Adenocarcinoma Acinar Type;5-SPOP;3;4;T2;;N0;56;MALE;Alive;27.83;NA;66;DiseaseFree;27.83
TCGA-HC-8259;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;50;MALE;Alive;30.35;NA;123;DiseaseFree;30.35
TCGA-HC-8260;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;43;MALE;Alive;22.54;NA;106;DiseaseFree;22.54
TCGA-HC-8261;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;;;48;MALE;Alive;17.94;NA;62;DiseaseFree;17.94
TCGA-HC-8262;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T2;;N0;57;MALE;Alive;22.31;NA;76;DiseaseFree;22.31
TCGA-HC-8264;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;;N1;60;MALE;Alive;1.58;NA;48;DiseaseFree;1.58
TCGA-HC-8265;Prostate Adenocarcinoma Acinar Type;6-FOXA1;3;4;T3;;N0;66;MALE;Alive;15.87;NA;70;DiseaseFree;15.87
TCGA-HC-8266;Prostate Adenocarcinoma Acinar Type;8-other;3;2;T3;M0;N0;55;MALE;Alive;15.54;NA;35;DiseaseFree;15.54
TCGA-HC-A48F;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N1;47;MALE;Alive;22.34;NA;46;DiseaseFree;22.34
TCGA-HC-A4ZV;Prostate Adenocarcinoma Acinar Type;8-other;2;2;T3;;N0;56;MALE;Alive;0.76;NA;23;DiseaseFree;0.76
TCGA-HC-A631;Prostate Adenocarcinoma Acinar Type;2-ETV1;2;2;T2;M0;N0;67;MALE;Alive;1.77;NA;54;DiseaseFree;1.77
TCGA-HC-A632;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;68;MALE;Alive;2;NA;61;DiseaseFree;2
TCGA-HC-A6AL;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;64;MALE;Alive;2.2;NA;67;DiseaseFree;2.2
TCGA-HC-A6AN;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;67;MALE;Alive;1.61;NA;49;DiseaseFree;1.61
TCGA-HC-A6AO;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;52;MALE;Alive;17.41;NA;167;DiseaseFree;17.41
TCGA-HC-A6AP;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;61;MALE;Alive;2.33;NA;71;DiseaseFree;2.33
TCGA-HC-A6AQ;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;60;MALE;Alive;3.48;NA;106;DiseaseFree;3.48
TCGA-HC-A6AS;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;70;MALE;Alive;1.45;NA;44;DiseaseFree;1.45
TCGA-HC-A6HX;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;55;MALE;Alive;1.25;NA;38;DiseaseFree;1.25
TCGA-HC-A6HY;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;51;MALE;Alive;4.4;NA;134;DiseaseFree;4.4
TCGA-HC-A76W;Prostate Adenocarcinoma Acinar Type;3-ETV4;3;2;T3;M0;N0;73;MALE;Alive;7;NA;213;DiseaseFree;7
TCGA-HC-A76X;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;62;MALE;Alive;4.93;NA;150;DiseaseFree;4.93
TCGA-HC-A8CY;Prostate Adenocarcinoma Acinar Type;2-ETV1;2;2;T3;M0;N1;63;MALE;Alive;9.53;NA;290;DiseaseFree;9.53
TCGA-HC-A8D0;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;61;MALE;Alive;25.46;NA;110;DiseaseFree;25.46
TCGA-HC-A8D1;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;68;MALE;Alive;18.82;NA;168;DiseaseFree;18.82
TCGA-HC-A9TE;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;64;MALE;Alive;19.28;NA;134;Recurred/Progressed;7.1
TCGA-HC-A9TH;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;58;MALE;Alive;27.73;NA;295;Recurred/Progressed;11.53
TCGA-HI-7168;Prostate Adenocarcinoma Acinar Type;3-ETV4;3;2;T3;M0;N0;62;MALE;Alive;109.17;NA;2315;Recurred/Progressed;82.29
TCGA-HI-7169;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;55;MALE;Alive;88.17;NA;1949;DiseaseFree;88.17
TCGA-HI-7170;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T2;M0;N0;58;MALE;Alive;82.85;NA;1780;DiseaseFree;82.85
TCGA-HI-7171;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;56;MALE;Dead;43.66;1329;NA;NA;NA
TCGA-J4-8198;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;;49;MALE;Alive;20.17;NA;98;DiseaseFree;20.17
TCGA-J4-8200;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;47;MALE;Alive;40.01;NA;196;DiseaseFree;40.01
TCGA-J4-A67K;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;68;MALE;Alive;32.98;NA;662;DiseaseFree;32.98
TCGA-J4-A67L;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;54;MALE;Alive;25.3;NA;518;DiseaseFree;25.3
TCGA-J4-A67M;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;55;MALE;Alive;30.91;NA;488;DiseaseFree;30.91
TCGA-J4-A67N;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;61;MALE;Alive;30.78;NA;503;Recurred/Progressed;14.52
TCGA-J4-A67O;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;59;MALE;Alive;27.56;NA;491;DiseaseFree;27.56
TCGA-J4-A67Q;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;77;MALE;Alive;32.03;NA;624;DiseaseFree;32.03
TCGA-J4-A67R;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;65;MALE;Alive;29.89;NA;454;DiseaseFree;29.89
TCGA-J4-A67S;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;63;MALE;Alive;27.37;NA;523;Recurred/Progressed;23.26
TCGA-J4-A67T;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;;63;MALE;Alive;6.01;NA;183;DiseaseFree;6.01
TCGA-J4-A6G1;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T3;M0;N0;68;MALE;Alive;25.26;NA;405;DiseaseFree;25.26
TCGA-J4-A6G3;Prostate Adenocarcinoma Acinar Type;5-SPOP;3;2;T3;M0;N0;57;MALE;Alive;27.89;NA;528;Recurred/Progressed;20.3
TCGA-J4-A6M7;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;;53;MALE;Alive;16.82;NA;279;DiseaseFree;16.82
TCGA-J4-A83I;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;63;MALE;Alive;22.5;NA;279;DiseaseFree;22.5
TCGA-J4-A83J;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;68;MALE;Alive;22.86;NA;310;DiseaseFree;22.86
TCGA-J4-A83K;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;;52;MALE;Alive;10.78;NA;206;DiseaseFree;10.78
TCGA-J4-A83L;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;61;MALE;Alive;23.65;NA;316;DiseaseFree;23.65
TCGA-J4-A83M;Prostate Adenocarcinoma Acinar Type;2-ETV1;1;2;T2;M0;N0;64;MALE;Alive;17.84;NA;437;Recurred/Progressed;17.12
TCGA-J4-A83N;Prostate Adenocarcinoma Acinar Type;1-ERG;1;3;T2;M0;;57;MALE;Alive;32.59;NA;617;Recurred/Progressed;14.22
TCGA-J4-AATV;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;71;MALE;Alive;18.17;NA;358;DiseaseFree;18.17
TCGA-J4-AATZ;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;66;MALE;Alive;13.53;NA;412;Recurred/Progressed;2.6
TCGA-J4-AAU2;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;59;MALE;Alive;27.1;NA;304;DiseaseFree;27.1
TCGA-J9-A52B;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;;N0;62;MALE;Alive;13.86;NA;422;Recurred/Progressed;1.87
TCGA-J9-A52C;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;;;57;MALE;Alive;5.85;NA;178;DiseaseFree;5.85
TCGA-J9-A52D;Prostate Adenocarcinoma, Other Subtype;NA;NA;NA;T3;M0;;71;MALE;Alive;6.96;NA;212;DiseaseFree;6.96
TCGA-J9-A52E;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;;N0;65;MALE;Alive;10.61;NA;323;DiseaseFree;10.61
TCGA-J9-A8CK;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;;66;MALE;Alive;10.55;NA;321;DiseaseFree;10.55
TCGA-J9-A8CL;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;;66;MALE;Alive;13.3;NA;405;Recurred/Progressed;4.34
TCGA-J9-A8CM;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;66;MALE;Alive;15.21;NA;463;Recurred/Progressed;11.3
TCGA-J9-A8CN;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;;53;MALE;Alive;40.64;NA;1237;DiseaseFree;40.64
TCGA-J9-A8CP;Prostate Adenocarcinoma Acinar Type;6-FOXA1;1;4;T3;M0;;66;MALE;Alive;12.68;NA;386;DiseaseFree;12.68
TCGA-KC-A4BL;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T2;M0;N0;65;MALE;Alive;30.68;NA;934;Recurred/Progressed;6.34
TCGA-KC-A4BN;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;55;MALE;Alive;59.63;NA;1815;DiseaseFree;59.63
TCGA-KC-A4BO;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;55;MALE;Alive;19.94;NA;607;DiseaseFree;19.94
TCGA-KC-A4BR;Prostate Adenocarcinoma Acinar Type;1-ERG;1;3;T3;M0;N1;75;MALE;Alive;44.32;NA;1349;Recurred/Progressed;33.57
TCGA-KC-A4BV;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;66;MALE;Alive;43.63;NA;1328;Recurred/Progressed;43.63
TCGA-KC-A7F3;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;67;MALE;Alive;21.85;NA;665;DiseaseFree;21.85
TCGA-KC-A7F5;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;54;MALE;Alive;2.99;NA;91;DiseaseFree;2.99
TCGA-KC-A7F6;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T2;M0;N0;63;MALE;Alive;8.64;NA;263;DiseaseFree;8.64
TCGA-KC-A7FA;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;N0;63;MALE;Alive;19.65;NA;598;DiseaseFree;19.65
TCGA-KC-A7FD;Prostate Adenocarcinoma Acinar Type;3-ETV4;1;2;T3;M0;N0;62;MALE;Alive;8.87;NA;270;DiseaseFree;8.87
TCGA-KC-A7FE;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;62;MALE;Alive;11.56;NA;352;DiseaseFree;11.56
TCGA-KK-A59V;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;64;MALE;Alive;113.01;NA;2859;DiseaseFree;113.01
TCGA-KK-A59X;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N1;55;MALE;Alive;83.28;NA;1712;Recurred/Progressed;73.36
TCGA-KK-A59Y;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;56;MALE;Alive;64.65;NA;1359;DiseaseFree;64.65
TCGA-KK-A59Z;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;66;MALE;Alive;86.33;NA;1879;DiseaseFree;86.33
TCGA-KK-A5A1;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;72;MALE;Dead;81.11;NA;2364;Recurred/Progressed;6.67
TCGA-KK-A6DY;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T2;M0;N0;50;MALE;Alive;141.1;NA;3524;DiseaseFree;141.1
TCGA-KK-A6E0;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N0;59;MALE;Alive;48.72;NA;913;Recurred/Progressed;30.91
TCGA-KK-A6E1;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;57;MALE;Alive;72.21;NA;1659;DiseaseFree;72.21
TCGA-KK-A6E2;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T2;M0;N0;54;MALE;Alive;165.05;NA;4604;DiseaseFree;165.05
TCGA-KK-A6E3;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;56;MALE;Alive;67.54;NA;2056;DiseaseFree;67.54
TCGA-KK-A6E4;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;69;MALE;Dead;115.05;NA;2753;NA;NA
TCGA-KK-A6E5;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N0;63;MALE;Alive;68.1;NA;1498;DiseaseFree;68.1
TCGA-KK-A6E6;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;69;MALE;Alive;113.24;NA;3447;DiseaseFree;113.24
TCGA-KK-A6E7;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;46;MALE;Alive;90.67;NA;2040;Recurred/Progressed;30.39
TCGA-KK-A6E8;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;68;MALE;Alive;58.15;NA;1770;DiseaseFree;58.15
TCGA-KK-A7AP;Prostate Adenocarcinoma Acinar Type;2-ETV1;2;1;T3;M0;N1;55;MALE;Alive;6.44;NA;196;DiseaseFree;6.44
TCGA-KK-A7AQ;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;62;MALE;Alive;52.89;NA;1386;Recurred/Progressed;39.98
TCGA-KK-A7AU;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;63;MALE;Alive;58.31;NA;1621;Recurred/Progressed;6.8
TCGA-KK-A7AV;Prostate Adenocarcinoma Acinar Type;8-other;3;2;T2;M0;N0;58;MALE;Alive;27;NA;822;DiseaseFree;27
TCGA-KK-A7AW;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;57;MALE;Alive;34.63;NA;1054;DiseaseFree;34.63
TCGA-KK-A7AY;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;60;MALE;Alive;57.62;NA;1572;Recurred/Progressed;36.93
TCGA-KK-A7AZ;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;;N0;56;MALE;Alive;49.9;NA;840;DiseaseFree;49.9
TCGA-KK-A7B0;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;67;MALE;Alive;43.66;NA;999;Recurred/Progressed;19.91
TCGA-KK-A7B1;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;65;MALE;Alive;34.92;NA;1063;DiseaseFree;34.92
TCGA-KK-A7B2;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;68;MALE;Alive;36.1;NA;692;Recurred/Progressed;22.73
TCGA-KK-A7B3;Prostate Adenocarcinoma Acinar Type;2-ETV1;2;1;T3;M0;N0;62;MALE;Alive;29.53;NA;637;Recurred/Progressed;9.66
TCGA-KK-A7B4;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;64;MALE;Alive;32.42;NA;637;Recurred/Progressed;31.64
TCGA-KK-A8I4;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;64;MALE;Alive;74.21;NA;2068;Recurred/Progressed;71.02
TCGA-KK-A8I5;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T2;M0;N0;55;MALE;Alive;101.71;NA;2553;DiseaseFree;101.71
TCGA-KK-A8I6;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;58;MALE;Alive;21.94;NA;668;DiseaseFree;21.94
TCGA-KK-A8I7;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;55;MALE;Alive;65.77;NA;1891;Recurred/Progressed;57.69
TCGA-KK-A8I8;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;69;MALE;Alive;31.77;NA;774;DiseaseFree;31.77
TCGA-KK-A8I9;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N0;61;MALE;Alive;32.88;NA;721;Recurred/Progressed;30.88
TCGA-KK-A8IA;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N1;69;MALE;Alive;63.44;NA;1439;DiseaseFree;63.44
TCGA-KK-A8IB;Prostate Adenocarcinoma Acinar Type;6-FOXA1;1;2;T3;M0;N0;65;MALE;Alive;2.73;NA;83;DiseaseFree;2.73
TCGA-KK-A8IC;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;54;MALE;Alive;67.38;NA;2051;Recurred/Progressed;34.82
TCGA-KK-A8ID;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N1;70;MALE;Alive;69.22;NA;1973;DiseaseFree;69.22
TCGA-KK-A8IF;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N0;57;MALE;Alive;26.41;NA;804;Recurred/Progressed;21.29
TCGA-KK-A8IG;Prostate Adenocarcinoma Acinar Type;6-FOXA1;1;4;T3;M0;N0;55;MALE;Alive;82.29;NA;2211;DiseaseFree;82.29
TCGA-KK-A8IH;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;50;MALE;Alive;66.13;NA;1635;DiseaseFree;66.13
TCGA-KK-A8II;Prostate Adenocarcinoma, Other Subtype;1-ERG;2;3;T3;M0;N0;61;MALE;Dead;113.9;3467;NA;Recurred/Progressed;60.91
TCGA-KK-A8IJ;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N1;59;MALE;Alive;51.22;NA;1559;Recurred/Progressed;10.09
TCGA-KK-A8IK;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;4;T2;M0;N0;56;MALE;Alive;67.41;NA;1563;DiseaseFree;67.41
TCGA-KK-A8IL;Prostate Adenocarcinoma Acinar Type;8-other;3;2;T3;M0;N1;65;MALE;Dead;20.63;628;NA;NA;NA
TCGA-KK-A8IM;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;55;MALE;Alive;62.91;NA;1438;DiseaseFree;62.91
TCGA-M7-A71Y;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;4;T2;;;55;MALE;Alive;16.2;NA;158;DiseaseFree;16.2
TCGA-M7-A71Z;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;;N0;62;MALE;Alive;21.12;NA;209;DiseaseFree;21.12
TCGA-M7-A720;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T2;;;53;MALE;Alive;12.61;NA;302;DiseaseFree;12.61
TCGA-M7-A721;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;;70;MALE;Alive;13.14;NA;204;DiseaseFree;13.14
TCGA-M7-A722;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;65;MALE;Alive;34.82;NA;717;Recurred/Progressed;18.36
TCGA-M7-A723;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;54;MALE;Alive;25.07;NA;62;DiseaseFree;25.07
TCGA-M7-A724;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;64;MALE;Alive;29.2;NA;483;DiseaseFree;29.2
TCGA-M7-A725;Prostate Adenocarcinoma Acinar Type;3-ETV4;2;2;T3;M0;N0;56;MALE;Alive;18.82;NA;96;DiseaseFree;18.82
TCGA-MG-AAMC;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;59;MALE;Alive;5.68;NA;173;DiseaseFree;5.68
TCGA-QU-A6IL;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;64;MALE;Alive;3.19;NA;97;DiseaseFree;3.19
TCGA-QU-A6IM;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;59;MALE;Alive;40.97;NA;1247;DiseaseFree;40.97
TCGA-QU-A6IN;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;61;MALE;Alive;140.08;NA;3487;DiseaseFree;140.08
TCGA-QU-A6IO;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;53;MALE;Alive;122.08;NA;1436;DiseaseFree;122.08
TCGA-QU-A6IP;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;66;MALE;Alive;86.07;NA;2620;DiseaseFree;86.07
TCGA-SU-A7E7;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;4;T2;M0;N0;60;MALE;Alive;18.1;NA;112;DiseaseFree;18.1
TCGA-TK-A8OK;Prostate Adenocarcinoma Acinar Type;8-other;3;1;;M0;;73;MALE;Alive;0.89;NA;27;DiseaseFree;0.89
TCGA-TP-A8TT;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;64;MALE;Alive;17.28;NA;362;DiseaseFree;17.28
TCGA-TP-A8TV;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;62;MALE;Alive;20.04;NA;249;DiseaseFree;20.04
TCGA-V1-A8MF;Prostate Adenocarcinoma Acinar Type;8-other;3;2;T3;M0;N0;65;MALE;Alive;47.6;NA;1254;DiseaseFree;47.6
TCGA-V1-A8MG;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;;53;MALE;Alive;28.15;NA;857;DiseaseFree;28.15
TCGA-V1-A8MJ;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;4;T3;M0;N1;58;MALE;Alive;58.84;NA;1230;DiseaseFree;58.84
TCGA-V1-A8MK;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;41;MALE;Alive;16.69;NA;508;DiseaseFree;16.69
TCGA-V1-A8ML;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;N0;63;MALE;Alive;14.72;NA;448;DiseaseFree;14.72
TCGA-V1-A8MM;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;60;MALE;Alive;39.26;NA;1019;Recurred/Progressed;32.52
TCGA-V1-A8MU;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;N1;56;MALE;Alive;61.63;NA;1399;DiseaseFree;61.63
TCGA-V1-A8WL;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;N0;64;MALE;Alive;63.99;NA;1375;DiseaseFree;63.99
TCGA-V1-A8WN;Prostate Adenocarcinoma Acinar Type;4-FLI1;3;4;T2;M0;;47;MALE;Alive;30.35;NA;476;DiseaseFree;30.35
TCGA-V1-A8WS;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;;56;MALE;Alive;15.57;NA;474;DiseaseFree;15.57
TCGA-V1-A8WV;Prostate Adenocarcinoma Acinar Type;3-ETV4;2;4;T3;M0;N1;52;MALE;Alive;22.54;NA;686;DiseaseFree;22.54
TCGA-V1-A8WW;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;59;MALE;Alive;35.41;NA;709;DiseaseFree;35.41
TCGA-V1-A8X3;Prostate Adenocarcinoma Acinar Type;3-ETV4;1;2;T2;M0;N0;51;MALE;Alive;6.64;NA;202;DiseaseFree;6.64
TCGA-V1-A9O5;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T4;M0;N1;64;MALE;Alive;63.47;NA;1776;Recurred/Progressed;4.07
TCGA-V1-A9O5;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T4;M0;N1;64;MALE;Alive;63.47;NA;1776;Recurred/Progressed;4.07
TCGA-V1-A9O7;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;60;MALE;Alive;82.1;NA;2425;Recurred/Progressed;26.91
TCGA-V1-A9O9;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;56;MALE;Alive;94.28;NA;204;DiseaseFree;94.28
TCGA-V1-A9OA;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;61;MALE;Alive;20.89;NA;636;DiseaseFree;20.89
TCGA-V1-A9OF;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;49;MALE;Alive;38.9;NA;1184;DiseaseFree;38.9
TCGA-V1-A9OH;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;63;MALE;Alive;78.94;NA;1253;DiseaseFree;78.94
TCGA-V1-A9OL;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;65;MALE;Alive;62.84;NA;589;Recurred/Progressed;3.45
TCGA-V1-A9OQ;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;;67;MALE;Alive;12.19;NA;371;DiseaseFree;12.19
TCGA-V1-A9OT;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;61;MALE;Alive;15.64;NA;476;Recurred/Progressed;9.59
TCGA-V1-A9OX;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;56;MALE;Alive;37.25;NA;256;DiseaseFree;37.25
TCGA-V1-A9OY;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;57;MALE;Alive;35.05;NA;170;DiseaseFree;35.05
TCGA-V1-A9Z7;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;54;MALE;Alive;28.71;NA;123;DiseaseFree;28.71
TCGA-V1-A9Z8;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;59;MALE;Alive;27.17;NA;187;DiseaseFree;27.17
TCGA-V1-A9Z9;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;63;MALE;Alive;17.74;NA;295;DiseaseFree;17.74
TCGA-V1-A9ZG;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;64;MALE;Alive;49.84;NA;1117;DiseaseFree;49.84
TCGA-V1-A9ZI;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;68;MALE;Alive;53.88;NA;86;DiseaseFree;53.88
TCGA-V1-A9ZK;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;68;MALE;Alive;45.43;NA;1049;DiseaseFree;45.43
TCGA-V1-A9ZR;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T4;M0;N0;68;MALE;Alive;44.71;NA;177;DiseaseFree;44.71
TCGA-VN-A88I;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;N0;59;MALE;Alive;8.84;NA;269;DiseaseFree;8.84
TCGA-VN-A88K;Prostate Adenocarcinoma Acinar Type;1-ERG;2;4;T3;M0;N1;58;MALE;Alive;25.49;NA;776;DiseaseFree;25.49
TCGA-VN-A88L;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;M0;N0;54;MALE;Alive;24.51;NA;394;DiseaseFree;24.51
TCGA-VN-A88M;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;55;MALE;Alive;6.21;NA;183;DiseaseFree;6.21
TCGA-VN-A88N;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;62;MALE;Alive;25.16;NA;176;DiseaseFree;25.16
TCGA-VN-A88O;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;49;MALE;Alive;15.8;NA;481;DiseaseFree;15.8
TCGA-VN-A88P;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;60;MALE;Alive;41.39;NA;917;DiseaseFree;41.39
TCGA-VN-A88Q;Prostate Adenocarcinoma, Other Subtype;1-ERG;2;3;T2;M0;N0;60;MALE;Alive;44.88;NA;1001;DiseaseFree;44.88
TCGA-VN-A88R;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;53;MALE;Alive;25.76;NA;459;Recurred/Progressed;16.82
TCGA-VN-A943;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;71;MALE;Alive;16.29;NA;132;DiseaseFree;16.29
TCGA-VP-A872;Prostate Adenocarcinoma, Other Subtype;1-ERG;2;3;T3;M0;N0;60;MALE;Alive;119.28;NA;3253;DiseaseFree;119.28
TCGA-VP-A875;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;67;MALE;Alive;75.85;NA;805;DiseaseFree;75.85
TCGA-VP-A876;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T2;;N0;46;MALE;Alive;109.49;NA;2576;DiseaseFree;109.49
TCGA-VP-A878;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;;N1;58;MALE;Alive;102.83;NA;2704;Recurred/Progressed;77.33
TCGA-VP-A879;Prostate Adenocarcinoma Acinar Type;1-ERG;3;3;T2;M0;N0;70;MALE;Dead;23.92;728;NA;NA;NA
TCGA-VP-A87B;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;63;MALE;Alive;89.42;NA;2309;Recurred/Progressed;81.24
TCGA-VP-A87C;Prostate Adenocarcinoma Acinar Type;1-ERG;3;1;T2;M0;N0;67;MALE;Alive;55.52;NA;1690;DiseaseFree;55.52
TCGA-VP-A87D;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;54;MALE;Alive;60.87;NA;1853;Recurred/Progressed;39.22
TCGA-VP-A87E;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;59;MALE;Alive;66.92;NA;2037;DiseaseFree;66.92
TCGA-VP-A87H;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N0;76;MALE;Alive;21.78;NA;663;DiseaseFree;21.78
TCGA-VP-A87J;Prostate Adenocarcinoma Acinar Type;2-ETV1;1;4;T3;M0;N1;56;MALE;Alive;58.28;NA;1296;DiseaseFree;58.28
TCGA-VP-A87K;Prostate Adenocarcinoma, Other Subtype;1-ERG;2;3;T3;M0;N0;63;MALE;Alive;42.9;NA;655;Recurred/Progressed;22.9
TCGA-VP-AA1N;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;70;MALE;Alive;44.84;NA;542;DiseaseFree;44.84
TCGA-WW-A8ZI;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;N0;70;MALE;Alive;14.75;NA;176;DiseaseFree;14.75
TCGA-X4-A8KQ;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;65;MALE;Alive;45.43;NA;1131;DiseaseFree;45.43
TCGA-X4-A8KS;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;61;MALE;Alive;32.16;NA;846;DiseaseFree;32.16
TCGA-XA-A8JR;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T2;M0;N0;68;MALE;Alive;12.35;NA;119;DiseaseFree;12.35
TCGA-XJ-A83F;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;;N0;67;MALE;Alive;37.02;NA;762;DiseaseFree;37.02
TCGA-XJ-A83G;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;;N0;51;MALE;Alive;48;NA;1157;DiseaseFree;48
TCGA-XJ-A83H;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T2;M0;;57;MALE;Alive;42.05;NA;1280;DiseaseFree;42.05
TCGA-XJ-A9DI;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T3;M0;N0;62;MALE;Alive;48;NA;1461;DiseaseFree;48
TCGA-XJ-A9DK;Prostate Adenocarcinoma Acinar Type;1-ERG;3;4;T2;M0;;63;MALE;Alive;9.03;NA;275;DiseaseFree;9.03
TCGA-XJ-A9DQ;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;;48;MALE;Alive;2.99;NA;91;DiseaseFree;2.99
TCGA-XJ-A9DX;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M1;N1;51;MALE;Alive;31.96;NA;790;DiseaseFree;31.96
TCGA-XK-AAIR;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;75;MALE;Alive;31.93;NA;972;DiseaseFree;31.93
TCGA-XK-AAIV;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;63;MALE;Alive;37.22;NA;958;DiseaseFree;37.22
TCGA-XK-AAIW;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;78;MALE;Alive;40.01;NA;972;Recurred/Progressed;14.03
TCGA-XK-AAJ3;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;56;MALE;Alive;41.46;NA;868;DiseaseFree;41.46
TCGA-XK-AAJA;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;62;MALE;Alive;30.55;NA;930;DiseaseFree;30.55
TCGA-XK-AAJP;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;66;MALE;Alive;41.36;NA;889;DiseaseFree;41.36
TCGA-XK-AAJR;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;61;MALE;Alive;36.93;NA;824;Recurred/Progressed;4.3
TCGA-XK-AAJT;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;75;MALE;Alive;47.11;NA;1126;DiseaseFree;47.11
TCGA-XK-AAJU;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;65;MALE;Alive;51.77;NA;1206;DiseaseFree;51.77
TCGA-XK-AAK1;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T2;M0;N0;62;MALE;Alive;32.16;NA;614;DiseaseFree;32.16
TCGA-XQ-A8TA;Prostate Adenocarcinoma Acinar Type;3-ETV4;1;2;;M1;;59;MALE;Dead;4.8;146;NA;NA;NA
TCGA-XQ-A8TB;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;67;MALE;Alive;25.3;NA;770;DiseaseFree;25.3
TCGA-Y6-A8TL;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;;N0;65;MALE;Alive;32.59;NA;775;DiseaseFree;32.59
TCGA-Y6-A9XI;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;;;N0;72;MALE;Alive;17.28;NA;526;DiseaseFree;17.28
TCGA-YJ-A8SW;Prostate Adenocarcinoma, Other Subtype;8-other;1;2;T3;;N0;67;MALE;Alive;4.86;NA;148;DiseaseFree;4.86
TCGA-YL-A8HJ;Prostate Adenocarcinoma, Other Subtype;1-ERG;1;3;T3;M0;;58;MALE;Alive;52.92;NA;1611;DiseaseFree;52.92
TCGA-YL-A8HK;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;59;MALE;Alive;48.98;NA;1491;Recurred/Progressed;45.2
TCGA-YL-A8HL;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N1;58;MALE;Alive;51.41;NA;1173;DiseaseFree;51.41
TCGA-YL-A8HM;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N0;66;MALE;Alive;48.69;NA;1124;Recurred/Progressed;48.39
TCGA-YL-A8HO;Prostate Adenocarcinoma Acinar Type;8-other;3;2;T3;M0;N0;67;MALE;Alive;75.69;NA;2183;Recurred/Progressed;35.09
TCGA-YL-A8S8;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N0;68;MALE;Alive;62.09;NA;1890;Recurred/Progressed;22.31
TCGA-YL-A8S9;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N0;63;MALE;Alive;60.51;NA;1842;Recurred/Progressed;33.05
TCGA-YL-A8SA;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;N0;69;MALE;Alive;16.82;NA;512;DiseaseFree;16.82
TCGA-YL-A8SB;Prostate Adenocarcinoma Acinar Type;8-other;1;4;T3;M0;N0;62;MALE;Alive;56.47;NA;1384;Recurred/Progressed;45.47
TCGA-YL-A8SC;Prostate Adenocarcinoma Acinar Type;2-ETV1;2;2;T3;M0;N0;66;MALE;Alive;41.43;NA;1261;Recurred/Progressed;4.99
TCGA-YL-A8SF;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N0;62;MALE;Alive;45.11;NA;1373;DiseaseFree;45.11
TCGA-YL-A8SH;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;N0;69;MALE;Dead;28.75;875;NA;NA;NA
TCGA-YL-A8SI;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;69;MALE;Alive;53.02;NA;1441;Recurred/Progressed;46.75
TCGA-YL-A8SJ;Prostate Adenocarcinoma Acinar Type;2-ETV1;3;2;T3;M0;N0;60;MALE;Alive;45.83;NA;1395;Recurred/Progressed;24.7
TCGA-YL-A8SK;Prostate Adenocarcinoma Acinar Type;8-other;3;2;T3;M0;N1;67;MALE;Alive;46.25;NA;1155;DiseaseFree;46.25
TCGA-YL-A8SL;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N1;74;MALE;Alive;32.42;NA;798;DiseaseFree;32.42
TCGA-YL-A8SO;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T3;M0;;64;MALE;Alive;114.29;NA;3247;DiseaseFree;114.29
TCGA-YL-A8SP;Prostate Adenocarcinoma Acinar Type;1-ERG;2;3;T3;M0;;58;MALE;Alive;77.73;NA;2170;Recurred/Progressed;66.89
TCGA-YL-A8SQ;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N0;61;MALE;Alive;68.43;NA;1943;Recurred/Progressed;10.81
TCGA-YL-A8SR;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N0;64;MALE;Alive;8.97;NA;213;DiseaseFree;8.97
TCGA-YL-A9WH;Prostate Adenocarcinoma Acinar Type;2-ETV1;2;2;T3;M0;N1;67;MALE;Alive;14.03;NA;427;DiseaseFree;14.03
TCGA-YL-A9WI;Prostate Adenocarcinoma Acinar Type;6-FOXA1;1;2;T3;M0;N1;63;MALE;Alive;53.32;NA;1259;DiseaseFree;53.32
TCGA-YL-A9WJ;Prostate Adenocarcinoma Acinar Type;8-other;3;4;T3;M0;N1;47;MALE;Dead;60.94;1855;NA;Recurred/Progressed;48.49
TCGA-YL-A9WK;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;63;MALE;Alive;70.17;NA;1897;Recurred/Progressed;33.15
TCGA-YL-A9WL;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;59;MALE;Alive;24.31;NA;740;Recurred/Progressed;24.31
TCGA-YL-A9WX;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;68;MALE;Alive;49.87;NA;1518;Recurred/Progressed;49.47
TCGA-YL-A9WY;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;57;MALE;Alive;36.07;NA;846;Recurred/Progressed;32.03
TCGA-ZG-A8QW;Prostate Adenocarcinoma Acinar Type;8-other;1;2;T3;M0;N1;72;MALE;Alive;3.09;NA;50;DiseaseFree;3.09
TCGA-ZG-A8QX;Prostate Adenocarcinoma Acinar Type;5-SPOP;1;2;T2;M0;N0;56;MALE;Alive;14.52;NA;150;DiseaseFree;14.52
TCGA-ZG-A8QY;Prostate Adenocarcinoma Acinar Type;5-SPOP;3;2;T3;M0;N1;67;MALE;Alive;13.27;NA;34;DiseaseFree;13.27
TCGA-ZG-A8QZ;Prostate Adenocarcinoma Acinar Type;1-ERG;2;1;T3;M0;N1;65;MALE;Alive;10.12;NA;308;DiseaseFree;10.12
TCGA-ZG-A9KY;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T4;M0;N1;73;MALE;Alive;4.27;NA;34;DiseaseFree;4.27
TCGA-ZG-A9L0;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;71;MALE;Alive;11.66;NA;68;DiseaseFree;11.66
TCGA-ZG-A9L1;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;66;MALE;Alive;42.77;NA;1147;DiseaseFree;42.77
TCGA-ZG-A9L2;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;70;MALE;Alive;37.91;NA;986;Recurred/Progressed;5.91
TCGA-ZG-A9L4;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;61;MALE;Alive;36.4;NA;1108;DiseaseFree;36.4
TCGA-ZG-A9L5;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T4;M0;N1;58;MALE;Alive;29.83;NA;854;DiseaseFree;29.83
TCGA-ZG-A9L6;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;64;MALE;Alive;22.57;NA;664;Recurred/Progressed;21.81
TCGA-ZG-A9L9;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;60;MALE;Alive;20.27;NA;602;Recurred/Progressed;1.68
TCGA-ZG-A9LB;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;72;MALE;Alive;19.15;NA;485;DiseaseFree;19.15
TCGA-ZG-A9LM;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;72;MALE;Alive;12.42;NA;121;DiseaseFree;12.42
TCGA-ZG-A9LN;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;57;MALE;Alive;3.78;NA;115;DiseaseFree;3.78
TCGA-ZG-A9LS;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;64;MALE;Alive;16.95;NA;211;DiseaseFree;16.95
TCGA-ZG-A9LU;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;67;MALE;Alive;19.02;NA;549;DiseaseFree;19.02
TCGA-ZG-A9LY;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;60;MALE;Alive;12.16;NA;287;DiseaseFree;12.16
TCGA-ZG-A9LZ;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;66;MALE;Alive;22.73;NA;692;DiseaseFree;22.73
TCGA-ZG-A9M4;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;65;MALE;Alive;17.97;NA;223;DiseaseFree;17.97
TCGA-ZG-A9MC;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;69;MALE;Alive;14.95;NA;428;DiseaseFree;14.95
TCGA-ZG-A9N3;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N1;73;MALE;Alive;11.47;NA;244;DiseaseFree;11.47
TCGA-ZG-A9ND;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;55;MALE;Alive;13.47;NA;261;DiseaseFree;13.47
TCGA-ZG-A9NI;Prostate Adenocarcinoma Acinar Type;NA;NA;NA;T3;M0;N0;73;MALE;Alive;4.34;NA;132;DiseaseFree;4.34
